Meyka Pro banner
Care Capital Properties, Inc.

Stay Updated with the Latest Care Capital Properties, Inc. CCP News in Real Time

Find CCP news now at Meyka AI. Stay informed with the latest Care Capital Properties, Inc. stocks updates, including price news, market analysis, and expert insights.

CCP●NYSE
Real EstateREIT - Healthcare Facilities
$24.21
$0.00(0.00%)
U.S. Market opens in 16h 41m
House Passes $1.15 Trillion Defense Bill With Iran War Funding, Department of War Rename
πŸ“… in about 3 hours

House Passes $1.15 Trillion Defense Bill With Iran War Funding, Department of War Rename

House passes $1.15 trillion NDAA with $73 billion Iran war funding, Department of Defense renamed to Department of War. Vote was 216-212. Bill heads to Senate.

Read more 12
Albanese Expands Paid Prac to 10 Health Fields, $338 Weekly Payments From July 2027
πŸ“… in about 1 hour

Albanese Expands Paid Prac to 10 Health Fields, $338 Weekly Payments From July 2027

Australian government expands Paid Prac to 10 health professions from July 2027, providing $338.60 weekly payments to eligible students during clinical placements. Total cost $158 million over four years.

Read more 12
Cracker Barrel Sells Maple Street Biscuit Co. to Biscuit Belly, Closes 16 Locations July 23
πŸ“… in 24 minutes

Cracker Barrel Sells Maple Street Biscuit Co. to Biscuit Belly, Closes 16 Locations July 23

Cracker Barrel sold Maple Street Biscuit Company to Biscuit Belly, closing 16 locations. The sale and a separate $77 million sale-leaseback deal aim to reduce debt and improve profitability.

Read more 12
Alphabet (NASDAQ: GOOGL) Raises 2026 Capex Outlook to $205 Billion as AI Infrastructure Spending Accelerates
πŸ“… 3 hours ago

Alphabet (NASDAQ: GOOGL) Raises 2026 Capex Outlook to $205 Billion as AI Infrastructure Spending Accelerates

Alphabet raised its full-year 2026 capital expenditure guidance to a range of $195 billion to $205 billion. That’s up sharply from the $180 billion to $190 billion forecast the company gave just last quarter. Alphabet posted Q2 2026 revenue of $119.8 billion, up 24% year-over-year, alongside record capital spending of $44.9 billion.Β  Shares fell 3.4%…

Read more 12
Tesla (NASDAQ: TSLA) Shares Fall 5% After Earnings Miss and Weaker Automotive Margins
πŸ“… 4 hours ago

Tesla (NASDAQ: TSLA) Shares Fall 5% After Earnings Miss and Weaker Automotive Margins

Tesla shares fell as much as 5.6% on July 23, 2026, a day after a disappointing Q2 earnings report. The stock touched an intraday low of $353.23, down from Wednesday’s close of $374.01. Tesla posted record second-quarter revenue of $28.24 billion, up 26% year-over-year, but adjusted earnings per share of $0.33 badly missed the $0.53…

Read more 12
Tesla Stock Falls 1.3% After Q2 Profit Miss, $25B Capex Plan July 23
πŸ“… 4 hours ago

Tesla Stock Falls 1.3% After Q2 Profit Miss, $25B Capex Plan July 23

Tesla misses Q2 earnings forecast despite record $28.24B revenue. Stock slides 1.3% as company plans $25B capex and $30B in new borrowing for AI and robotaxi expansion.

Read more 12
Alphabet Stock Sinks 1.2% as Q2 Earnings Beat Masked by $205B Capex Surge
πŸ“… 5 hours ago

Alphabet Stock Sinks 1.2% as Q2 Earnings Beat Masked by $205B Capex Surge

Alphabet beat Q2 earnings with $119.8B revenue and 82% cloud growth, but stock fell as capex jumped to $205B and free cash flow turned negative for the first time in a decade.

Read more 12
Eternal (NSE: ETERNAL) Shares Jump 4% After Strong Q1 Results as Analysts Turn Bullish on FY27
πŸ“… 6 hours ago

Eternal (NSE: ETERNAL) Shares Jump 4% After Strong Q1 Results as Analysts Turn Bullish on FY27

Eternal shares jumped as much as 4.5% on July 23, 2026, hitting an intraday high of β‚Ή296.15. The Zomato and Blinkit parent posted Q1 FY27 revenue of β‚Ή20,211 crore, up 182% year-on-year. Consolidated net profit climbed 268% to β‚Ή92 crore, though it fell 47% sequentially. Blinkit turned EBITDA-positive for the first time, swinging from a…

Read more 12
Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23
πŸ“… 6 hours ago

Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23

Generic Zyrtec cetirizine tablets recalled nationwide due to cross-contamination with ranitidine heartburn drug. Four lot numbers affected, expiring October 2028. No adverse events reported yet.

Read more 12

CCP News FAQ